The US Department of Veterans Affairs (VA) is expanding its use of precision medicine through a new multi-year contract with Baylor Genetics to provide pharmacogenomic (PGx) and germline genetic testing to veterans across the VA’s nationwide healthcare system. The agreement includes PGx testing as well as hereditary cancer analysis, supporting broader genomic integration within federal […]
To access this post, you must purchase The Dark Report.